{"id":"https://openalex.org/W4253729313","doi":"https://doi.org/10.1089/jir.1986.6.189","title":"Modulation of 2\u2032,5\u2032-Oligoadenylate Synthetase in Patients Treated with Alpha-Interferon: Effects of Dose, Schedule, and Route of Administration","display_name":"Modulation of 2\u2032,5\u2032-Oligoadenylate Synthetase in Patients Treated with Alpha-Interferon: Effects of Dose, Schedule, and Route of Administration","publication_year":1986,"publication_date":"1986-06-01","ids":{"openalex":"https://openalex.org/W4253729313","doi":"https://doi.org/10.1089/jir.1986.6.189"},"language":"en","primary_location":{"id":"doi:10.1089/jir.1986.6.189","doi":"https://doi.org/10.1089/jir.1986.6.189","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1986.6.189","pdf_url":null,"source":{"id":"https://openalex.org/S2755320784","display_name":"Journal of Interferon Research","issn_l":"0197-8357","issn":["0197-8357","2332-4007"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"JAMES A. MERRITT","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JAMES A. MERRITT","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108620407","display_name":"L. Andrew Ball","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. ANDREW BALL","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032809309","display_name":"KAREN M. SIELAFF","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KAREN M. SIELAFF","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005220396","display_name":"DEBORAH M. MELTZER","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DEBORAH M. MELTZER","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112252438","display_name":"Ernest C. Borden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ERNEST C. BORDEN","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6426,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.85060789,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"6","issue":"3","first_page":"189","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-5-oligoadenylate-synthetase","display_name":"2',5'-oligoadenylate synthetase","score":0.9620000123977661},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9539999961853027},{"id":"https://openalex.org/keywords/enzyme-induction","display_name":"enzyme induction","score":0.7200000286102295},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.9200000166893005},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.8500000238418579},{"id":"https://openalex.org/keywords/interferon-bioassay","display_name":"interferon bioassay","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.6720080375671387},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.630731999874115},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.6007033586502075},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.5739971995353699},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5430528521537781},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.5355550646781921},{"id":"https://openalex.org/C28212737","wikidata":"https://www.wikidata.org/wiki/Q5381543","display_name":"Enzyme assay","level":3,"score":0.4834059774875641},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47167760133743286},{"id":"https://openalex.org/C132154277","wikidata":"https://www.wikidata.org/wiki/Q5381545","display_name":"Enzyme inducer","level":3,"score":0.4595881700515747},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.41992971301078796},{"id":"https://openalex.org/C2780841837","wikidata":"https://www.wikidata.org/wiki/Q24741149","display_name":"Interferon gamma","level":3,"score":0.41727426648139954},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4092952609062195},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40826618671417236},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3763795495033264},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3387638330459595},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33618760108947754},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31519603729248047},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28596144914627075},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2754212021827698},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20406219363212585}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1089/jir.1986.6.189","doi":"https://doi.org/10.1089/jir.1986.6.189","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1986.6.189","pdf_url":null,"source":{"id":"https://openalex.org/S2755320784","display_name":"Journal of Interferon Research","issn_l":"0197-8357","issn":["0197-8357","2332-4007"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2427051697","display_name":null,"funder_award_id":"CM-07434-01","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306095","display_name":"American Cancer Society","ror":"https://ror.org/02e463172"},{"id":"https://openalex.org/F4320309434","display_name":"University of Wisconsin-Madison","ror":"https://ror.org/01y2jtd41"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1965595006","https://openalex.org/W1986557372","https://openalex.org/W2010532053","https://openalex.org/W2041861141","https://openalex.org/W2044299821","https://openalex.org/W2058187175","https://openalex.org/W2070598185","https://openalex.org/W2076668534","https://openalex.org/W2083345395","https://openalex.org/W2089079415","https://openalex.org/W2316021304","https://openalex.org/W2320616888","https://openalex.org/W2328776927","https://openalex.org/W2329348469","https://openalex.org/W2345499595"],"related_works":["https://openalex.org/W2058319538","https://openalex.org/W2329348469","https://openalex.org/W2316021304","https://openalex.org/W2013108724","https://openalex.org/W2109107521","https://openalex.org/W1965336695","https://openalex.org/W2069013641","https://openalex.org/W2316670571","https://openalex.org/W1626617912","https://openalex.org/W2024121673"],"abstract_inverted_index":{"The":[0,29,38,56,88],"interferon":[1,27],"(IFN)-induced":[2],"intracellular":[3],"enzyme":[4,32,54,62,89],"2\u2032,5\u2032-oligoadenylate":[5],"(2-5A)":[6],"synthetase":[7,117],"was":[8,34,64,71,91,100],"measured":[9],"in":[10],"extracts":[11],"of":[12,23,25,31,60,67,76,80,86,96,102,105,113],"peripheral":[13],"mononuclear":[14],"cells":[15],"isolated":[16],"from":[17,43],"patients":[18],"receiving":[19],"a":[20,65,92,114],"300-fold":[21],"range":[22,30],"doses":[24],"alpha":[26],"(IFN-\u03b1).":[28],"induction":[33],"2.3-":[35],"to":[36,45,73,83],"5.7-fold.":[37],"maximum":[39,53],"fold":[40],"increase":[41],"varied":[42],"individual":[44,46],"as":[47],"did":[48],"the":[49,61,74,84,103,111],"dose":[50,69],"required":[51],"for":[52,119],"stimulation.":[55],"magnitude":[57],"and":[58,70],"endurance":[59],"response":[63],"function":[66],"IFN":[68,97,121],"unrelated":[72],"duration":[75],"treatment":[77],"or":[78,82],"number":[79],"injections":[81],"route":[85],"administration.":[87],"assay":[90,118],"more":[93],"sensitive":[94],"indicator":[95],"administration":[98],"than":[99],"measurement":[101],"level":[104],"circulating":[106],"IFN.":[107],"These":[108],"results":[109],"substantiate":[110],"potential":[112],"clinical":[115],"2-5A":[116],"monitoring":[120],"treatment.":[122]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-05-12T00:00:00"}